Skip to main content
ARDELYX, INC. logo

ARDELYX, INC. — Investor Relations & Filings

Ticker · ARDX ISIN · US0396971071 LEI · 549300F542QR4SXHCY32 US Manufacturing
Filings indexed 1,077 across all filing types
Latest filing 2026-05-19 Proxy Solicitation & In…
Country US United States of America
Listing US ARDX

About ARDELYX, INC.

https://www.ardelyx.com/

Ardelyx, Inc. is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines to address unmet medical needs. The company's primary therapeutic areas of focus are cardiorenal and gastrointestinal diseases. Its key commercial product is XPHOZAH® (tenapanor), a novel mechanism therapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Ardelyx also develops treatments for Irritable Bowel Syndrome with Constipation (IBS-C), aiming to advance patient care through its portfolio of innovative therapies.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement
2026-05-19 English
4 - ARDELYX, INC. (0001437402) (Issuer)
Director's Dealing
2026-03-18 English
4 - ARDELYX, INC. (0001437402) (Filer)
Director's Dealing
2026-02-25 English
4 - ARDELYX, INC. (0001437402) (Filer)
Director's Dealing
2026-02-24 English
4 - ARDELYX, INC. (0001437402) (Filer)
Director's Dealing
2026-02-24 English
4 - ARDELYX, INC. (0001437402) (Filer)
Director's Dealing
2026-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.